Alogliptin + Metformin

Composition

This formulation contains alogliptin and Metformin as active ingrediant

Indications

This combination Formulation is used to treat type 2 diabetes mellitus.

Side effects

Common side effects may include diarrhea, nausea, vomiting, abdominal discomfort, and headache.

Precautions

Use with caution in patients with kidney disease, liver disease, or heart failure.

Contraindications

Contraindicated in patients having kidney disease, liver disease, or metabolic acidosis.

Dosage and administration

As directed by physician, Once or twice a daily with foods

Countries

Worldwide

Available Forms

Tablet

Manufacturing Services

Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai